ARCHIVES

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

This article is from The Cancer Letter archive.

Vol. 24 No. 35 | September 18, 1998

Download PDF Visit The Full Archive

Related Articles

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

NCI Clarifies P01 Grant Application Dates

September 13, 1996

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013